mHealth Intelligence December 6, 2019
The FDA’s new CURE ID mHealth app will allow clinicians to post their own experiences in treating complex and unusual diseases, find relevant studies and collaborate with their peers across the globe.
Federal officials have unveiled an mHealth platform that will allow healthcare providers to share ideas on treating complex infectious diseases.
The CURE ID platform, unveiled this week by the US Food and Drug Administration, collects case reports from clinicians using FDA-approved drugs and allows clinicians to chat with peers and review ongoing and proposed clinical trials. The global connected health service was created by the FDA in collaboration with the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS).
“The CURE ID application focuses on drugs...
Today's Sponsors
Today's Sponsor